Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-25 @ 12:46 AM
Study NCT ID:
NCT06615557
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2024-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Sponsor:
VistaGen Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Social Anxiety Disorder (SAD) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Fasedienol | View |
| None | PH94B | View |
| None | social anxiety disorder | View |
| None | social anxiety | View |
| None | SAD | View |
| None | pherine | View |
| None | pherine nasal spray | View |
| None | acute treatment | View |
| None | anxiolytic | View |
| None | mental health | View |
| None | anxiety | View |
| None | performance anxiety | View |
| None | anxiety nasal spray | View |
| None | anxiety treatment | View |
| None | public speaking anxiety | View |
| None | social phobia | View |
| None | phobic disorders | View |
| None | mental disorder | View |
| None | speech task | View |